Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2012
10/17/2012CN102741271A IMP-3 oligopeptides and vaccines including the same
10/17/2012CN102740889A Therapies for preventing or suppressing clostridium difficile infection
10/17/2012CN102740888A Antibodies to IL-6 and use there
10/17/2012CN102740887A Combination immunotherapy for the treatment of cancer
10/17/2012CN102740886A Use of vap-1 inhibitors for treating fibrotic conditions
10/17/2012CN102740885A Treatment of cancer involving mutated kras or braf genes
10/17/2012CN102740884A Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
10/17/2012CN102740883A Adjuvant for the preparation of vaccine compositions intended for the prevention of coccidiosis
10/17/2012CN102740882A Adjuvant comprising aluminium, oligonucleotide and polycation
10/17/2012CN102740881A Method for orthopoxvirus production and purification
10/17/2012CN102740880A Universal influenza vaccine based on recombinant modified vaccinia ankara virus (MVA)
10/17/2012CN102740879A Immunization compositions and methods
10/17/2012CN102740878A Streptococcal combi-vaccine
10/17/2012CN102740877A Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
10/17/2012CN102740872A Methods and compositions for providing protective immunity in the elderly
10/17/2012CN102740832A Arranging interaction and back pressure chambers for microfluidization
10/17/2012CN102735809A Method for determining content of polymer conjugate in Hib conjugate vaccine
10/17/2012CN102732608A Marker for diagnosing liver cancer and application thereof
10/17/2012CN102732550A Expression of human s1CD80 protein in Pichia pastoris system
10/17/2012CN102732544A A method for expelling a bacillus anthracis virulence large plasmid pXO1
10/17/2012CN102732533A Vaccine produced by using Cryptocaryon irritans immbolization antigen to complement deoxyribonucleic acid, and production method and application thereof
10/17/2012CN102732510A Method for simultaneously removing bacillus anthracis virulence megaplasmids pXO1 and pXO2
10/17/2012CN102732486A Porcine circovirus type2 strain and application thereof
10/17/2012CN102732473A Recombinant salmonella choleraesuis expressing mycoplasma hyopneumoniae p46 protein, preparation method and application thereof
10/17/2012CN102732472A Construction and application of attenuated Salmonella choleraesuis for expressing mycoplasma hyopneumoniae p65 protein
10/17/2012CN102731660A Preparation and application of GIT fusion protein used for preventing dairy cow mastitis
10/17/2012CN102731654A High affinity antibodies against hmgb1 and methods of use thereof
10/17/2012CN102731652A Preparation method of nanoliposome anti-bovine mastitis drug-resistant pathogenic bacteria specific composite IgY and its preparation
10/17/2012CN102731651A Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
10/17/2012CN102731649A Chicken-derived single-chain antibody against Newcastle disease virus, its preparation method and application
10/17/2012CN102731623A Murine original monoclonal antibody 3D8 identified hantaan virus glycoprotein neutralizing epitope peptide and application thereof
10/17/2012CN102731617A Hantaan virus glucoprotein specific T cell epitope peptide and application thereof
10/17/2012CN102731616A Tetanus-toxin-neutralizing B cell epitope peptide and application thereof
10/17/2012CN102727908A Oral gene vaccine for enterovirus, and preparation and application thereof
10/17/2012CN102727904A Heat resisting protective agent of bivalent live vaccine against highly pathogenic porcine reproductive and respiratory syndrome-pseudorabies and preparation method thereof
10/17/2012CN102727903A Heatproof lyophilized protective agent for live vaccine JXA1-R strain for highly pathogenic porcine reproductive and respiratory syndrome and method for preparing the same
10/17/2012CN102727902A Use method for chicken coccidiosis vaccine suspending agent and preparation method for suspension
10/17/2012CN102727895A Pharmaceutical composition for targeting treatment of intractable epilepsy
10/17/2012CN102727890A Application of anti-recombinant human keratinocyte growth factor-2 antibody
10/17/2012CN102727889A Application of specific antibodies in preparation of biological products for controlling virus infection based on virus acceptor binding site selection
10/17/2012CN102727888A Application of anti-human T lymphocyte CD3 surface antigen monoclonal antibody in preparation of drug for treating diabetic nephropathy
10/17/2012CN102727887A Application of chitosan serving as immuno-adjuvant in preparing mouse allergic asthma model
10/17/2012CN102727886A Preparation method of immunostimulatory injection for livestock
10/17/2012CN102727885A Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
10/17/2012CN102727884A Combined live vaccine against porcine reproductive and respiratory syndrome and pseudorabies, and preparation method thereof
10/17/2012CN102727883A Combined live vaccine against porcine reproductive and respiratory syndrome and swine fever, and application thereof
10/17/2012CN102727882A Combined live vaccine against porcine reproductive and respiratory syndrome, swine fever and pseudorabies, and preparation method thereof
10/17/2012CN102727881A Highly pathogenic porcine reproductive and respiratory syndrome JXAl-R strain- porcine parvovirus disease bigeminal live vaccine and preparation method and application thereof
10/17/2012CN102727880A Genetically engineered swine influenza virus and uses thereof
10/17/2012CN102727879A Spinner bottle production method of inactivated singapore grouper iridovirus (SGIV) vaccine
10/17/2012CN102727878A Preparation method of porcine reproductive and respiratory syndrome inactivated vaccine (NVDC-JXA1 strain) by bioreactor and application thereof
10/17/2012CN102727877A Method for preparing highly pathogenic porcine reproductive and respiratory syndrome live vaccine (JXA1-R strain) by utilizing bioreactor and application thereof
10/17/2012CN102727876A Preparation technology of oral vaccine for resisting salmonella
10/17/2012CN102727875A Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
10/17/2012CN102727861A Treatment of t-cell mediated diseases
10/17/2012CN102727631A Immunostimulatory injection for livestock
10/17/2012CN102727524A Application of CIK (cytokine induced killer) cell loaded by anti-CD3/anti-CD133 bispecific antibody
10/17/2012CN102727498A Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
10/17/2012CN102726617A Feed additive composed of cellulose and sodium bicarbonate, feed and applications of feed additive and feed, as well as chicken coccidiosis live oocyst vaccine
10/17/2012CN102242132B Enterovirus 71 capsid protein 1 antigen, preparation method and immunodetection reagent
10/17/2012CN102154365B Swine influenza virus H1N1 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof
10/17/2012CN101991864B Leptospira interrogans DNA (Deoxyribose Nucleic Acid) vaccine as well as construction method and application thereof
10/17/2012CN101896502B A human anti-tumor necrosis factor alpha monoclonal antibody and use thereof
10/17/2012CN101880324B Monoclonal antibody of anti-human SIRPalpha, cell strain, preparation method and application thereof
10/17/2012CN101691405B Fusion antigen uses as vaccine
10/17/2012CN101497881B Vaccine reading frame crosslinking with human molecule adjuvant hC3d3 same sense mutant
10/17/2012CN101495146B Muscle regeneration promoter
10/17/2012CN101287760B Anti-IL13 human antibodies
10/17/2012CN101219216B Method for preparing coexpression PRRSV ORF3 and ORF5 double-gene nucleic acid vaccine
10/17/2012CN101115772B Cytotoxic antibody directed against type-B lymphoid haematopoietic prolifeeations
10/16/2012US8288608 Transgenic animal expressing alzheimer's tau protein
10/16/2012US8288509 Therapeutic agent for infections, and treatment method using the same
10/16/2012US8288352 Auristatins having an aminobenzoic acid unit at the N terminus
10/16/2012US8288145 Medium supplement for virus production
10/16/2012US8288125 Intergenic regions as insertion sites in the genome of modified vaccinia virus Ankara (MVA)
10/16/2012US8287887 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
10/16/2012US8287886 Tuberculosis vaccine
10/16/2012US8287885 GAS57 mutant antigens and GAS57 antibodies
10/16/2012US8287884 Staphylococcus aureus proteins and nucleic acids
10/16/2012US8287883 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof
10/16/2012US8287882 Flagellin related polypeptides and uses thereof
10/16/2012US8287881 Synthetic gagpol genes and their uses
10/16/2012US8287880 Lipidated vaccine against dengue virus infection
10/16/2012US8287879 Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
10/16/2012US8287878 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
10/16/2012US8287877 Composition comprising immunogenic microparticles
10/16/2012US8287876 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
10/16/2012US8287875 Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
10/16/2012US8287874 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
10/16/2012US8287873 Vascular endothelial cell growth factor antagonists and uses thereof
10/16/2012US8287872 Methods for treating inflammatory conditions using antibodies that bind PAR-2
10/16/2012US8287871 Methods of inducing cell death of an activated T cell with anti-PSGL-1 antibodies
10/16/2012US8287870 Human cytomegalovirus neutralizing antibodies and use thereof
10/16/2012US8287869 Method of treating inflammatory disease by inhibition of IL-17 production
10/16/2012US8287868 bone morphogenic proteins; transforming growth factors; fusion proteins; drug screening; cardiovascular disorders
10/16/2012US8287867 Ovr115 antibody compositions and methods of use
10/16/2012US8287866 Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors
10/16/2012US8287865 Class I anti-CEA antibodies and uses thereof
10/16/2012US8287864 Structural variants of antibodies for improved therapeutic characteristics
10/16/2012US8287863 Method for treating myeloma utilizing an expression enhancer for HM1.24 antigen
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 1823